Director General of Indian Council of Medical Research, Balram Bhargava on September 15 informed about the COVID-19 vaccines trial stage in India.
Mumbai: Drugmaker Cadila Healthcare Ltd has launched in India the first bio similar version of the anti-inflammatory medicine adalimumab, the world's top-selling drug, at a fifth of its US price. The drug's branded version is
Top News
Latest News
